Lataa...
An orally delivered small-molecule formulation with antiangiogenic and anticancer activity
Targeting angiogenesis, the formation of blood vessels, is an important modality for cancer therapy. TNP-470, a fumagillin analog, is among the most potent and broad-spectrum angiogenesis inhibitors. However, a major clinical limitation is its poor oral availability and short half-life, necessitatin...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2803109/ https://ncbi.nlm.nih.gov/pubmed/18587385 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt1415 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|